Carregant...
含不同剂量去甲氧柔红霉素的IA方案诱导治疗成人初发急性髓系白血病的疗效和安全性研究
OBJECTIVE: To investigate the efficacy and safety of IA regimen which contains idarubicin (IDA) 8 mg/m(2), 10 mg/m(2) or 12 mg/m(2) as induction chemotherapy for adult patients with de-novo acute myeloid leukemia (AML). METHODS: A total of 1 215 newly diagnosed adult AML patients, ranging from May 2...
Guardat en:
| Publicat a: | Zhonghua Xue Ye Xue Za Zhi |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Editorial office of Chinese Journal of Hematology
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7342198/ https://ncbi.nlm.nih.gov/pubmed/29365393 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.12.003 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|